<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kazmin, Aleksey</style></author><author><style face="normal" font="default" size="100%">Wong, Renee C.</style></author><author><style face="normal" font="default" size="100%">Sermer, Mathew</style></author><author><style face="normal" font="default" size="100%">Koren, Gideon</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Antiepileptic drugs in pregnancy and hemorrhagic disease of the newborn</style></title><secondary-title><style face="normal" font="default" size="100%">Canadian Family Physician</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">1291-1292</style></pages><volume><style face="normal" font="default" size="100%">56</style></volume><issue><style face="normal" font="default" size="100%">12</style></issue><abstract><style  face="normal" font="default" size="100%">QUESTION What is the current evidence regarding the association between hemorrhagic disease of the newborn and maternal use of hepatic enzyme-inducing antiepileptic drugs (eg, carbamazepine, phenobarbitone, topiramate)? ANSWER Women with epilepsy who take enzyme-inducing antiepileptic drugs should be advised that there is no adequate evidence to support or refute taking vitamin K in late pregnancy to prevent bleeding complications in a newborn.</style></abstract></record></records></xml>